Clinical Trial Update: Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating cadonilimab plus regorafenib and gemcitabine-cisplatin chemotherapy in advanced biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Cadonilimab
• Regorafenib (regorafenib)
• gemcitabine/cisplatin

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Advanced Biliary Tract Cancer | Phase 2 | Status: UNKNOWN